The American Journal of Medicine
Volume 120, Issue 8 , Pages 678-684.e1 , August 2007

Upper Extremity Deep Vein Thrombosis: A Community-Based Perspective

  • Frederick A. Spencer, MD

      Affiliations

    • Department of Medicine, University of Massachusetts Medical School, Worcester
    • Department of Medicine, McMaster University Medical Center, Hamilton, Ont, Canada.
    • Corresponding Author InformationRequests for reprints should be addressed to Frederick A. Spencer, MD, Department of Medicine, McMaster University - Faculty of Health Sciences, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.
    • ,
  • Cathy Emery, RN

      Affiliations

    • Department of Medicine, University of Massachusetts Medical School, Worcester
    • ,
  • Darleen Lessard, MS

      Affiliations

    • Department of Medicine, University of Massachusetts Medical School, Worcester
    • ,
  • Robert J. Goldberg, PhD

      Affiliations

    • Department of Medicine, University of Massachusetts Medical School, Worcester
    • ,
  • The Worcester Venous Thromboembolism Study

References 

  1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism (A 25-year population-based study). Arch Intern Med. 1998;158:585–593
  2. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ Deep Vein Thrombosis (deep vein thrombosis) FREE Steering Committee. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation. 2004;110:1605–1611
  3. Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162:1245–1248
  4. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med. 1990;112:423–428
  5. Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J. 2002;32:84–88
  6. Masci G, Magagnoli M, Zucali PA, et al. Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?. J Clin Oncol. 2003;21:736–739
  7. Monreal M, Alastrue A, Rull M, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low-molecular weight heparin (Fragmin). Thromb Haemost. 1996;75:251–253
  8. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease. Chest. 2004;126:401S–428S
  9. Prandoni P, Polistena P, Bernardi E, et al. Upper-extremity deep vein thrombosis: risk factors, diagnosis, and complications. Arch Intern Med. 1997;157:57–62

 This study was supported by a grant from the National Heart, Lung, and Blood Institute (R01-HL70283), Bethesda, Md.

PII: S0002-9343(06)00909-0

doi: 10.1016/j.amjmed.2006.06.046

The American Journal of Medicine
Volume 120, Issue 8 , Pages 678-684.e1 , August 2007

Article Tools